The markets in which EastPharma operates are characterised by their fragmented nature, offering significant opportunities for industry consolidation. For example, in Turkey, Russia, Kazakhstan and Ukraine, the top ten pharmaceutical companies only control between 30-35% of their respective markets. The total market size of these four countries in 2006 was US$19.3bn. EastPharma’s strategy is to increase its market share, whilst at the same time seeking growth in higher margin products.

Market Share in terms of Units in Turkey in 2007